On December 4, 2025, the ALS app will be presented at the"ALS App Europe Initiative Meeting" at the International Symposium…
We are pleased to introduce an important new feature in the ALS app today: The new OPM classification is now…
The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis (ALS), in which important findings…
The patient survey on eye control glasses is a nationwide, systematic survey of patients with amyotrophic lateral sclerosis (ALS). The…
The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis (ALS), in which important findings…
The pilot phase, in which the APST seal was tested on selected care partner websites, began at the start of…
Donate your data for better care with the support of the Outpatient Partner Registry Study. The Outpatient Partner Registry Study…
Edaravone is approved in Japan under the name Radicut and in the USA under the trade name Radicava for the…
In January 2018, the international journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration published the results of a care management program…
The Federal Ministry of Education and Research (BMBF) has launched a competition for research funding for innovative platform ideas. In…